Risk Stratification of Differentiated Thyroid Carcinoma Patients: Does It Make A Clinically Meaningful Difference?

被引:0
|
作者
Ryan, P. [1 ]
Baban, C. K. [1 ]
Devane, L. A. [1 ]
McDermott, E. [1 ]
Curran, A. J. [2 ]
Devoy, D. [1 ]
Crowley, R. [3 ]
Salib, O. [4 ]
Gibbons, D. [5 ]
Prichard, R. [1 ]
机构
[1] St Vincents Univ Hosp, Dept Breast & Endocrine Surg, Elm Pk, Dublin 4, Ireland
[2] St Vincents Univ Hosp, Dept Otolaryngol, Elm Pk, Dublin 4, Ireland
[3] St Vincents Univ Hosp, Dept Endocrinol, Elm Pk, Dublin 4, Ireland
[4] St Lukess Hosp, Dept Radiat Oncol, Highfield Rd, Dublin 6, Ireland
[5] St Vincents Univ Hosp, Dept Pathol, Elm Pk, Dublin 4, Ireland
关键词
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
32
引用
收藏
页码:S326 / S327
页数:2
相关论文
共 50 条
  • [21] Risk Stratification in Differentiated Thyroid Cancer: An Ongoing Process
    Omry-Orbach, Gal
    RAMBAM MAIMONIDES MEDICAL JOURNAL, 2016, 7 (01):
  • [22] Clinical Assessment and Risk Stratification in Differentiated Thyroid Cancer
    Vaisman, Fernanda
    Tuttle, R. Michael
    ENDOCRINOLOGY AND METABOLISM CLINICS OF NORTH AMERICA, 2019, 48 (01) : 99 - +
  • [23] Prognosis and risk stratification in young papillary thyroid carcinoma patients
    Kuo, Sheng-Fong
    Chao, Tzu-Chieh
    Hsueh, Chuen
    Chuang, Wen-Yu
    Yang, Chung-Han
    Lin, Jen-Der
    ENDOCRINE JOURNAL, 2008, 55 (02) : 269 - 275
  • [24] Risk stratification in patients with anaplastic thyroid carcinoma: role of age
    Wang, Mingjun
    Wei, Tao
    Gong, Rixiang
    Zhu, Jingqiang
    Li, Zhihui
    ENDOCRINE, 2022, 77 (02) : 305 - 318
  • [25] How reliable is secondary risk stratification with stimulated thyroglobulin in patients with differentiated thyroid carcinoma? Results from a retrospective study
    Lemb, J.
    Huefner, M.
    Meller, B.
    Homayounfar, K.
    Sahlmann, C.
    Meller, J.
    NUKLEARMEDIZIN-NUCLEAR MEDICINE, 2013, 52 (03): : 88 - 96
  • [26] Thyroid disorders in obese patients. Does insulin resistance make a difference?
    Racataianu, Nicoleta
    Leach, Nicoleta
    Bondor, Cosmina Ioana
    Marza, Smaranda
    Moga, Daniela
    Valea, Ana
    Ghervan, Cristina
    ARCHIVES OF ENDOCRINOLOGY METABOLISM, 2017, 61 (06): : 575 - 583
  • [27] Business Process Simulation with Differentiated Resources: Does it Make a Difference?
    Lopez-Pintado, Orlenys
    Dumas, Marlon
    BUSINESS PROCESS MANAGEMENT (BPM 2022), 2022, 13420 : 361 - 378
  • [28] Does Difference Make a Difference in Financial Planning for Risk?
    Quilgars, Deborah
    Jones, Anwen
    Abbott, David
    SOCIAL POLICY & ADMINISTRATION, 2008, 42 (06) : 576 - 592
  • [29] Ductal carcinoma in situ with and without microinvasion: is there a clinically meaningful difference in outcome?
    Canas-Marques, Rita
    Schnitt, Stuart J.
    BRITISH JOURNAL OF CANCER, 2023, 128 (05) : 713 - 714
  • [30] Does the ATA Risk Stratification Apply to Patients with Papillary Thyroid Microcarcinoma?
    Stefanova, Dessislava I.
    Bose, Arpita
    Ullmann, Timothy M.
    Limberg, Jessica N.
    Finnerty, Brendan M.
    Zarnegar, Rasa
    Fahey, Thomas J.
    Beninato, Toni
    WORLD JOURNAL OF SURGERY, 2020, 44 (02) : 452 - 460